Literature DB >> 8502343

Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey.

M Kessler1, B Hoen, D Mayeux, D Hestin, C Fontenaille.   

Abstract

A prospective epidemiologic survey of bacterial infections in chronic hemodialysis patients was conducted from September 1, 1989 to February 28, 1990 in 27 dialysis units. Of the 1,455 patients enrolled in the study, 55 presented 63 episodes of bacteremia (incidence of 0.7 bacteremia per 100 patient-months). The portal of entry of sepsis was the vascular access in 50.8% of the episodes. The causative microorganisms were most often gram-positive cocci (69.8%). 23% of the teremic patients had a serum ferritin > 1,000 micrograms/l versus 7% of the nonbacteremic infected patients (p = 0.005). 39.7% of the patients had undergone a surgical operation during the month preceding the bacteremia. Eight patients had a recurrence during the study period and 8 had a metastatic localization: spondylodiscitis 2, septic pulmonary embolus 2, endocarditis 1, arthritis 1, liver abscess 1 and endophthalmia 1. 66% of the episodes required a hospitalization that lasted an average of 20 days. Mortality rate was 6.3%. This prospective study showed a trend towards a reduction in incidence and mortality of bacteremia in patients on chronic hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8502343     DOI: 10.1159/000187285

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  27 in total

1.  Value of superficial cultures for prediction of catheter-related bloodstream infection in long-term catheters: a prospective study.

Authors:  M Guembe; P Martín-Rabadán; A Echenagusia; F Camúñez; G Rodríguez-Rosales; G Simó; M Echenagusia; E Bouza
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

2.  Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.

Authors:  Usama Feroze; Kamyar Kalantar-Zadeh; Kevin A Sterling; Miklos Z Molnar; Nazanin Noori; Debbie Benner; Vallabh Shah; Rama Dwivedi; Kenneth Becker; Csaba P Kovesdy; Dominic S Raj
Journal:  J Ren Nutr       Date:  2011-08-31       Impact factor: 3.655

3.  Is there a role for antiplatelet therapy in infective endocarditis? A review of current scientific evidence.

Authors:  Nandan S Anavekar; Joseph G Murphy
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

4.  Spondylodiscitis in patients under haemodyalisis.

Authors:  Ana Maria Cervan; Juan de Dios Colmenero; Alfonso Del Arco; Francisco Villanueva; Enrique Guerado
Journal:  Int Orthop       Date:  2011-12-03       Impact factor: 3.075

5.  Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit.

Authors:  D Tena; R Carranza; J R Barberá; S Valdezate; J M Garrancho; M Arranz; J A Sáez-Nieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

6.  Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors:  Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

7.  Chlorhexidine-based antiseptic solutions effectively reduce catheter-related bacteremia.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Anthony Billings; Rosa Diaz; Denise Francoeur; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2009-03-19       Impact factor: 3.714

8.  Infective Endocarditis in Patients with Kidney Failure: Chronic Dialysis and Kidney Transplant.

Authors:  James H.E. Ireland; James T. McCarthy
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

9.  The characteristics and outcome of bacteraemia in renal transplant recipients and non-transplant renal patients.

Authors:  Mark Melzer; Territa Santhakumaran; Catherine Welch
Journal:  Infection       Date:  2016-05-02       Impact factor: 3.553

10.  Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans.

Authors:  Julie K Zorman; Mark Esser; Michael Raedler; Barry N Kreiswirth; Dlawer A A Ala'Aldeen; Nicholas Kartsonis; Steven S Smugar; Annaliesa S Anderson; Tessie McNeely; Jean Marie Arduino
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.